Final results of the SAME (Swiss Analysis of Multiple Sclerosis) study comparing four disease-modifying treatments for multiple sclerosis

被引：0
|
作者：
Gobbi, C.
Zecca, C.
Linnebank, M.
Mueller, S.
Meier, R.
Borter, E.
Traber, M.
机构：
[1] Osped Civ, Lugano, Switzerland
[2] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
[3] Kantonsspital, St Gallen, Switzerland
[4] Biogen Dompe AG, Zug, Switzerland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P937
引用
收藏
页码：S422 / S422
页数：1
相关论文
共 50 条
  • [31] The effect of disease-modifying treatments on conversion to secondary progressive multiple sclerosis
    Brown, J. W. L.
    Coles, A.
    Horakova, D.
    Havrdova, E.
    Trojano, M.
    Izquierdo, G.
    Prat, A.
    Girard, M.
    Hupperts, R.
    Van Pesch, V.
    Ferraro, D.
    Alroughani, R.
    Bergamaschi, R.
    Pucci, E.
    Iuliano, G.
    Lechner-Scott, J.
    Spelman, T.
    Jokubaitis, V.
    Ramo-Tello, C.
    Spitaleri, D.
    Granella, F.
    Solaro, C.
    Ampapa, R.
    Deri, N.
    McCombe, P.
    Petersen, T.
    Van Wijmeersch, B.
    Prevost, J.
    Sanchez-Menoyo, J. L.
    Soysal, A.
    Barnett, M.
    Moore, F.
    Rice, C.
    Scolding, N.
    Wilkins, A.
    McGuigan, C.
    Hutchinson, M.
    Ziemssen, T.
    Pearson, O.
    Harding, K.
    Duquette, P.
    Lugaresi, A.
    Grammond, P.
    Grand'Maison, F.
    Terzi, M.
    Shaygannejad, V.
    Sola, P.
    Butzkueven, H.
    Kalincik, T.
    Robsertson, N.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 32 - 34
  • [32] How to switch disease-modifying treatments in multiple sclerosis: Guidelines from the French Multiple Sclerosis Society (SFSEP)
    Bigaut, Kevin
    Cohen, Mikael
    Durand-Dubief, Francoise
    Maillart, Elisabeth
    Planque, Evelyne
    Zephir, Helene
    Lebrun-Frenay, Christine
    de Seze, Jerome
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 53
  • [33] Established disease-modifying treatments in relapsing-remitting multiple sclerosis
    Oh, Jiwon
    O'Connor, Paul W.
    CURRENT OPINION IN NEUROLOGY, 2015, 28 (03) : 220 - 229
  • [34] Discontinuation of disease-modifying treatments in multiple sclerosis to plan a pregnancy: A retrospective registry study
    Villaverde-Gonzalez, Ramon
    Candeliere-Merlicco, Antonio
    Aranzazu Alonso-Frias, Maria
    Aparicio Castro, Eladio
    Carrillo Alcaraz, Andres
    Mallada Frechin, Javier
    Perez Sempere, Angel
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 46
  • [35] Emerging multiple sclerosis disease-modifying therapies
    Giacomini, Paul S.
    Darlington, Peter J.
    Bar-Or, Amit
    CURRENT OPINION IN NEUROLOGY, 2009, 22 (03) : 226 - 232
  • [36] Emerging Disease-Modifying Therapies in Multiple Sclerosis
    Perumal, Jai
    Khan, Omar
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2012, 14 (03) : 256 - 263
  • [37] Multiple sclerosis disease-modifying therapy and pregnancy
    Miller, Aaron E.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : 715 - 716
  • [38] Cost of disease-modifying therapies for multiple sclerosis
    Brown, Murray G.
    NEUROLOGY, 2015, 84 (21) : E181 - E185
  • [39] DISEASE-MODIFYING THERAPIES FOR MULTIPLE-SCLEROSIS
    CARTER, JL
    CNS DRUGS, 1995, 3 (02) : 99 - 114
  • [40] Disease-Modifying Treatment in Progressive Multiple Sclerosis
    Ciotti, John Robert
    Cross, Anne Haney
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2018, 20 (05)
12345